FDA Accepts New Drug Application for Verastem’s Duvelisib and Grants Priority Review

April 9, 2018

ArcherDX and Ambry Genetics to provide immune repertoire and CAR-T- related sequencing services

March 26, 2018

ArcherDX Closes $35 Million Series A Financing

March 20, 2018

Bicycle Therapeutics and Cancer Research UK Announce Initiation of First Clinical Study of a Bicyclic Peptide (Bicycle®)

February 13, 2018

Colorescience Introduces Total Eye 3-in-1 Renewal Therapy SPF 35

February 1, 2018

Astellas Completes Acquisition of Mitobridge, Inc.

January 23, 2018